A 5-year-old boy with chronic granulomatous disease (CGD) was treated with amphotericin B for an invasive pulmonary Aspergillus nidulans infection. The infection progressed during 6 wk of treatment despite the addition of interferon-gamma (IFN-gamma), filgrastim, and transfusions with donor granulocytes. Treatment with a novel antifungal triazole, voriconazole, resulted in an excellent clinical response.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1164/ajrccm.157.5.9709068 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!